Cargando…

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study

OBJECTIVE: The modified Rodnan skin score (mRSS) is often used as a primary outcome measure in systemic sclerosis (SSc) randomized clinical trials (RCTs). Previous cohort studies with predominantly European Caucasian patients showed that setting an upper limit of mRSS as a selection criterion for RC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihai, Carina, Dobrota, Rucsandra, Assassi, Shervin, Mayes, Maureen D., Distler, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437132/ https://www.ncbi.nlm.nih.gov/pubmed/32720753 http://dx.doi.org/10.1002/acr2.11165

Ejemplares similares

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
por: Dobrota, Rucsandra, et al.
Publicado: (2016)

Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis
por: Evers, Caroline, et al.
Publicado: (2021)

Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis
por: Zampatti, Norina, et al.
Publicado: (2021)

Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis
por: Nagy, Gabriella, et al.
Publicado: (2023)

Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study
por: Walker, Ulrich A., et al.
Publicado: (2018)

Osteopontin in Systemic Sclerosis and its Role in Dermal Fibrosis
por: Wu, Minghua, et al.
Publicado: (2012)

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
por: Farutin, Victor, et al.
Publicado: (2021)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort
por: Assassi, Shervin, et al.
Publicado: (2011)

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis
por: Müller, Bettina, et al.
Publicado: (2020)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2013)

Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array
por: Bien, Stephanie A., et al.
Publicado: (2016)

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2014)

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
por: Assassi, Shervin, et al.
Publicado: (2010)

Facial skin pores: a multiethnic study
por: Flament, Frederic, et al.
Publicado: (2015)

Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
por: Gourh, Pravitt, et al.
Publicado: (2010)

Nintedanib in Patients With Systemic Sclerosis–Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score
por: Kuwana, Masataka, et al.
Publicado: (2022)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
por: Assassi, Shervin, et al.
Publicado: (2022)

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer
por: Plym, Anna, et al.
Publicado: (2021)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment
por: Silva, Berenice Anabel, et al.
Publicado: (2020)

Jaccoud’s arthropathy in SLE: findings from a Latin American multiethnic population
por: Quintana, Rosana, et al.
Publicado: (2019)

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis
por: Jandali, Bochra, et al.
Publicado: (2022)

Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy
por: Volkmann, Elizabeth R., et al.
Publicado: (2023)

Association of Endocrine Disrupting Chemicals With the Metabolic Syndrome Among Women in the Multiethnic Cohort Study
por: Ihenacho, Ugonna, et al.
Publicado: (2023)

Improving Blood Pressure Control in a Large Multiethnic California Population Through Changes in Health Care Delivery, 2004–2012
por: Shaw, Kate M., et al.
Publicado: (2014)

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
por: Seibold, James R, et al.
Publicado: (2020)

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
por: Takata, Miki, et al.
Publicado: (2019)

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
por: Volkmann, Elizabeth R., et al.
Publicado: (2016)

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
por: Bernstein, Elana J., et al.
Publicado: (2022)

Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese
por: Wang, Jiucun, et al.
Publicado: (2014)

Periodontal Disease Associated With Interstitial Myocardial Fibrosis: The Multiethnic Study of Atherosclerosis
por: Doughan, Maria, et al.
Publicado: (2023)

Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
por: Weng, Tingting, et al.
Publicado: (2019)

Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study
por: Assassi, Shervin, et al.
Publicado: (2022)

A Polymorphism in TLR2 Is Associated With Arterial Thrombosis in a Multiethnic Population of Patients With Systemic Lupus Erythematosus
por: Kaiser, Rachel, et al.
Publicado: (2014)

Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien)
por: Buschulte, Katharina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2a835urfe8pv20qamor179b2u